Mansedumbre Reclamación cama roxadustat treatment for anemia in patients undergoing long term dialysis Gallo Frente al mar travesura
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis | Aging
Cureus | Safety and Effectiveness of Roxadustat in Dialysis-Dependent Patients With Renal Anemia: A Hospital-Based Cohort Study | Article
Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease - ScienceDirect
Frontiers | Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Frontiers | Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis - ScienceDirect
Frontiers | A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study - ScienceDirect
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis
Anemia management: a historical perspective - Kidney International Supplements
Drug trial shows efficacy in treating anemia in chronic kidney disease patients without dialysis
Iron metabolism and management: focus on chronic kidney disease - Kidney International Supplements
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis | NEJM
IJERPH | Free Full-Text | Whether Prolyl Hydroxylase Blocker—Roxadustat—In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?